(5S,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;(5R,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;3-[5-[(4S)-2-amino-1,4-dimethyl-5-(2-methylsulfanylpyrimidin-5-yl)-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]benzonitrile;3-[6-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]pyrazin-2-yl]benzonitrile;2-[4-[5-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]pyrazol-1-yl]acetonitrile;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclohexylbenzamide

C129H124Br2N30O7S3 — CID 159349916

IUPAC(5S,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;(5R,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;3-[5-[(4S)-2-amino-1,4-dimethyl-5-(2-methylsulfanylpyrimidin-5-yl)-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]benzonitrile;3-[6-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]pyrazin-2-yl]benzonitrile;2-[4-[5-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]pyrazol-1-yl]acetonitrile;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclohexylbenzamide
SMILESCN1C(=O)C[C@@](C)(c2cc(-c3cnn(CC#N)c3)cs2)N=C1N.CN1C(=O)C[C@@](C)(c2cncc(-c3cccc(C#N)c3)n2)N=C1N.CN1C(=O)[C@@H](c2ccc(-c3ccccc3)cc2)[C@@](C)(c2ccnc(Br)c2)N=C1N.CN1C(=O)[C@H](c2ccc(-c3ccccc3)cc2)[C@@](C)(c2ccnc(Br)c2)N=C1N.CSc1ncc(C2C(=O)N(C)C(N)=N[C@]2(C)c2cc(-c3cccc(C#N)c3)cs2)cn1.NC1=NC(c2ccccc2)(c2ccccc2)C(=O)N1Cc1cccc(C(=O)NC2CCCCC2)c1
InChIInChI=1S/C29H30N4O2.2C23H21BrN4O.C22H20N6OS2.C17H16N6O.C15H16N6OS/c30-28-32-29(23-13-4-1-5-14-23,24-15-6-2-7-16-24)27(35)33(28)20-21-11-10-12-22(19-21)26(34)31-25-17-8-3-9-18-25;2*1-23(18-12-13-26-19(24)14-18)20(21(29)28(2)22(25)27-23)17-10-8-16(9-11-17)15-6-4-3-5-7-15;1-22(17-8-15(12-31-17)14-6-4-5-13(7-14)9-23)18(19(29)28(2)20(24)27-22)16-10-25-21(30-3)26-11-16;1-17(7-15(24)23(2)16(19)22-17)14-10-20-9-13(21-14)12-5-3-4-11(6-12)8-18;1-15(6-13(22)20(2)14(17)19-15)12-5-10(9-23-12)11-7-18-21(8-11)4-3-16/h1-2,4-7,10-16,19,25H,3,8-9,17-18,20H2,(H2,30,32)(H,31,34);2*3-14,20H,1-2H3,(H2,25,27);4-8,10-12,18H,1-3H3,(H2,24,27);3-6,9-10H,7H2,1-2H3,(H2,19,22);5,7-9H,4,6H2,1-2H3,(H2,17,19)/t;20-,23+;20-,23-;18?,22-;17-;15-/m.01100/s1
InChIKeyLHESUZLBWZHWGE-SWTFDKNQSA-N
MW2462.62 g/mol
LogP19.46
Rot. Bonds21

About (5S,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;(5R,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;3-[5-[(4S)-2-amino-1,4-dimethyl-5-(2-methylsulfanylpyrimidin-5-yl)-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]benzonitrile;3-[6-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]pyrazin-2-yl]benzonitrile;2-[4-[5-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]pyrazol-1-yl]acetonitrile;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclohexylbenzamide

(5S,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;(5R,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;3-[5-[(4S)-2-amino-1,4-dimethyl-5-(2-methylsulfanylpyrimidin-5-yl)-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]benzonitrile;3-[6-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]pyrazin-2-yl]benzonitrile;2-[4-[5-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]pyrazol-1-yl]acetonitrile;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclohexylbenzamide (PubChem CID 159349916) has the molecular formula C129H124Br2N30O7S3 and a molecular weight of 2462.62 g/mol. Its IUPAC name is (5S,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;(5R,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;3-[5-[(4S)-2-amino-1,4-dimethyl-5-(2-methylsulfanylpyrimidin-5-yl)-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]benzonitrile;3-[6-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]pyrazin-2-yl]benzonitrile;2-[4-[5-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]pyrazol-1-yl]acetonitrile;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclohexylbenzamide.

Molecular Properties

Compound Name(5S,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;(5R,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;3-[5-[(4S)-2-amino-1,4-dimethyl-5-(2-methylsulfanylpyrimidin-5-yl)-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]benzonitrile;3-[6-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]pyrazin-2-yl]benzonitrile;2-[4-[5-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]pyrazol-1-yl]acetonitrile;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclohexylbenzamide
PubChem CID159349916
Molecular FormulaC129H124Br2N30O7S3
Molecular Weight2462.62 g/mol
Exact Mass2458.78
IUPAC Name(5S,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;(5R,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;3-[5-[(4S)-2-amino-1,4-dimethyl-5-(2-methylsulfanylpyrimidin-5-yl)-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]benzonitrile;3-[6-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]pyrazin-2-yl]benzonitrile;2-[4-[5-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]pyrazol-1-yl]acetonitrile;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclohexylbenzamide
SMILESCN1C(=O)C[C@@](C)(c2cc(-c3cnn(CC#N)c3)cs2)N=C1N.CN1C(=O)C[C@@](C)(c2cncc(-c3cccc(C#N)c3)n2)N=C1N.CN1C(=O)[C@@H](c2ccc(-c3ccccc3)cc2)[C@@](C)(c2ccnc(Br)c2)N=C1N.CN1C(=O)[C@H](c2ccc(-c3ccccc3)cc2)[C@@](C)(c2ccnc(Br)c2)N=C1N.CSc1ncc(C2C(=O)N(C)C(N)=N[C@]2(C)c2cc(-c3cccc(C#N)c3)cs2)cn1.NC1=NC(c2ccccc2)(c2ccccc2)C(=O)N1Cc1cccc(C(=O)NC2CCCCC2)c1
InChIInChI=1S/C29H30N4O2.2C23H21BrN4O.C22H20N6OS2.C17H16N6O.C15H16N6OS/c30-28-32-29(23-13-4-1-5-14-23,24-15-6-2-7-16-24)27(35)33(28)20-21-11-10-12-22(19-21)26(34)31-25-17-8-3-9-18-25;2*1-23(18-12-13-26-19(24)14-18)20(21(29)28(2)22(25)27-23)17-10-8-16(9-11-17)15-6-4-3-5-7-15;1-22(17-8-15(12-31-17)14-6-4-5-13(7-14)9-23)18(19(29)28(2)20(24)27-22)16-10-25-21(30-3)26-11-16;1-17(7-15(24)23(2)16(19)22-17)14-10-20-9-13(21-14)12-5-3-4-11(6-12)8-18;1-15(6-13(22)20(2)14(17)19-15)12-5-10(9-23-12)11-7-18-21(8-11)4-3-16/h1-2,4-7,10-16,19,25H,3,8-9,17-18,20H2,(H2,30,32)(H,31,34);2*3-14,20H,1-2H3,(H2,25,27);4-8,10-12,18H,1-3H3,(H2,24,27);3-6,9-10H,7H2,1-2H3,(H2,19,22);5,7-9H,4,6H2,1-2H3,(H2,17,19)/t;20-,23+;20-,23-;18?,22-;17-;15-/m.01100/s1
InChIKeyLHESUZLBWZHWGE-SWTFDKNQSA-N
XLogP19.46
TPSA547.77 Ų
H-Bond Donors7
H-Bond Acceptors33
Rotatable Bonds21
Heavy Atoms171
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002462.62
LogP ≤ 519.46
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1033

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}

Analyze (5S,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;(5R,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;3-[5-[(4S)-2-amino-1,4-dimethyl-5-(2-methylsulfanylpyrimidin-5-yl)-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]benzonitrile;3-[6-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]pyrazin-2-yl]benzonitrile;2-[4-[5-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]pyrazol-1-yl]acetonitrile;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclohexylbenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (5S,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;(5R,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;3-[5-[(4S)-2-amino-1,4-dimethyl-5-(2-methylsulfanylpyrimidin-5-yl)-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]benzonitrile;3-[6-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]pyrazin-2-yl]benzonitrile;2-[4-[5-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]pyrazol-1-yl]acetonitrile;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclohexylbenzamide?
The IUPAC name of (5S,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;(5R,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;3-[5-[(4S)-2-amino-1,4-dimethyl-5-(2-methylsulfanylpyrimidin-5-yl)-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]benzonitrile;3-[6-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]pyrazin-2-yl]benzonitrile;2-[4-[5-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]pyrazol-1-yl]acetonitrile;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclohexylbenzamide (CID 159349916) is (5S,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;(5R,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;3-[5-[(4S)-2-amino-1,4-dimethyl-5-(2-methylsulfanylpyrimidin-5-yl)-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]benzonitrile;3-[6-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]pyrazin-2-yl]benzonitrile;2-[4-[5-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]pyrazol-1-yl]acetonitrile;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclohexylbenzamide.
What is the SMILES notation for (5S,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;(5R,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;3-[5-[(4S)-2-amino-1,4-dimethyl-5-(2-methylsulfanylpyrimidin-5-yl)-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]benzonitrile;3-[6-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]pyrazin-2-yl]benzonitrile;2-[4-[5-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]pyrazol-1-yl]acetonitrile;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclohexylbenzamide?
The canonical SMILES for (5S,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;(5R,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;3-[5-[(4S)-2-amino-1,4-dimethyl-5-(2-methylsulfanylpyrimidin-5-yl)-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]benzonitrile;3-[6-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]pyrazin-2-yl]benzonitrile;2-[4-[5-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]pyrazol-1-yl]acetonitrile;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclohexylbenzamide is CN1C(=O)C[C@@](C)(c2cc(-c3cnn(CC#N)c3)cs2)N=C1N.CN1C(=O)C[C@@](C)(c2cncc(-c3cccc(C#N)c3)n2)N=C1N.CN1C(=O)[C@@H](c2ccc(-c3ccccc3)cc2)[C@@](C)(c2ccnc(Br)c2)N=C1N.CN1C(=O)[C@H](c2ccc(-c3ccccc3)cc2)[C@@](C)(c2ccnc(Br)c2)N=C1N.CSc1ncc(C2C(=O)N(C)C(N)=N[C@]2(C)c2cc(-c3cccc(C#N)c3)cs2)cn1.NC1=NC(c2ccccc2)(c2ccccc2)C(=O)N1Cc1cccc(C(=O)NC2CCCCC2)c1.
What is the InChIKey of (5S,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;(5R,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;3-[5-[(4S)-2-amino-1,4-dimethyl-5-(2-methylsulfanylpyrimidin-5-yl)-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]benzonitrile;3-[6-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]pyrazin-2-yl]benzonitrile;2-[4-[5-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]pyrazol-1-yl]acetonitrile;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclohexylbenzamide?
The InChIKey is LHESUZLBWZHWGE-SWTFDKNQSA-N. The full InChI is InChI=1S/C29H30N4O2.2C23H21BrN4O.C22H20N6OS2.C17H16N6O.C15H16N6OS/c30-28-32-29(23-13-4-1-5-14-23,24-15-6-2-7-16-24)27(35)33(28)20-21-11-10-12-22(19-21)26(34)31-25-17-8-3-9-18-25;2*1-23(18-12-13-26-19(24)14-18)20(21(29)28(2)22(25)27-23)17-10-8-16(9-11-17)15-6-4-3-5-7-15;1-22(17-8-15(12-31-17)14-6-4-5-13(7-14)9-23)18(19(29)28(2)20(24)27-22)16-10-25-21(30-3)26-11-16;1-17(7-15(24)23(2)16(19)22-17)14-10-20-9-13(21-14)12-5-3-4-11(6-12)8-18;1-15(6-13(22)20(2)14(17)19-15)12-5-10(9-23-12)11-7-18-21(8-11)4-3-16/h1-2,4-7,10-16,19,25H,3,8-9,17-18,20H2,(H2,30,32)(H,31,34);2*3-14,20H,1-2H3,(H2,25,27);4-8,10-12,18H,1-3H3,(H2,24,27);3-6,9-10H,7H2,1-2H3,(H2,19,22);5,7-9H,4,6H2,1-2H3,(H2,17,19)/t;20-,23+;20-,23-;18?,22-;17-;15-/m.01100/s1.
What are the key properties of (5S,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;(5R,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;3-[5-[(4S)-2-amino-1,4-dimethyl-5-(2-methylsulfanylpyrimidin-5-yl)-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]benzonitrile;3-[6-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]pyrazin-2-yl]benzonitrile;2-[4-[5-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]pyrazol-1-yl]acetonitrile;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclohexylbenzamide?
(5S,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;(5R,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;3-[5-[(4S)-2-amino-1,4-dimethyl-5-(2-methylsulfanylpyrimidin-5-yl)-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]benzonitrile;3-[6-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]pyrazin-2-yl]benzonitrile;2-[4-[5-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]pyrazol-1-yl]acetonitrile;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclohexylbenzamide has a molecular weight of 2462.62 g/mol, XLogP of 19.46, 21 rotatable bonds, 7 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for (5S,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;(5R,6S)-2-amino-6-(2-bromo-4-pyridinyl)-3,6-dimethyl-5-(4-phenylphenyl)-5H-pyrimidin-4-one;3-[5-[(4S)-2-amino-1,4-dimethyl-5-(2-methylsulfanylpyrimidin-5-yl)-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]benzonitrile;3-[6-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]pyrazin-2-yl]benzonitrile;2-[4-[5-[(4S)-2-amino-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]thiophen-3-yl]pyrazol-1-yl]acetonitrile;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-cyclohexylbenzamide is sourced from PubChem (CID 159349916), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).